ANI PHARMACEUTICALS INC. - COMMON STOCK

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

05 مايو 2025 08:52:17 بحسب NetDania Notify

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model

05 مايو 2025 06:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

02 مايو 2025 12:34:23 بحسب NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

29 أبريل 2025 11:06:34 بحسب NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

28 أبريل 2025 08:46:14 بحسب NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

25 أبريل 2025 12:49:24 بحسب NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

17 أبريل 2025 14:49:11 بحسب NetDania Notify

NetDania - New 12 months High: ANI PHARMACEUTICALS INC. - COMMON STOCK

16 أبريل 2025 10:51:13 بحسب NetDania Notify

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

09 أبريل 2025 05:50:00 بحسب Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

31 مارس 2025 15:30:00 بحسب Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

19 مارس 2025 05:50:00 بحسب Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

18 مارس 2025 05:50:00 بحسب Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

14 مارس 2025 05:50:00 بحسب Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe

03 مارس 2025 15:30:00 بحسب Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

28 فبراير 2025 05:50:16 بحسب Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March

19 فبراير 2025 15:30:00 بحسب Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET

18 فبراير 2025 15:05:00 بحسب Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference

28 يناير 2025 15:30:00 بحسب Nasdaq GlobeNewswire

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook

13 يناير 2025 05:50:00 بحسب Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity

02 يناير 2025 05:50:00 بحسب Nasdaq GlobeNewswire